Carmit Goldstein - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Carmit Goldstein

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Reproductive Biomedicine Online|December 10, 2002

Genotyping: the HLA system and embryo developmentCarol M Warner, David A Tyas, Carmit Goldstein, et al.

The Journal of Pharmacology and Experimental Therapeutics|September 14, 2010

Two naturally occurring mutations in the type 1 melanin-concentrating hormone receptor abolish agonist-induced signalingCarmit Goldstein, Jonathan C Schroeder, Jean-Philippe Fortin, et al.

Molecular Pharmacology|August 13, 2010

The μ-opioid receptor variant N190K is unresponsive to peptide agonists yet can be rescued by small-molecule drugsJean-Philippe Fortin, Lei Ci, Jonathan Schroeder, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Reproductive Biomedicine Online|December 10, 2002

Genotyping: the HLA system and embryo developmentCarol M Warner, David A Tyas, Carmit Goldstein, et al.

The Journal of Pharmacology and Experimental Therapeutics|September 14, 2010

Two naturally occurring mutations in the type 1 melanin-concentrating hormone receptor abolish agonist-induced signalingCarmit Goldstein, Jonathan C Schroeder, Jean-Philippe Fortin, et al.

Molecular Pharmacology|August 13, 2010

The μ-opioid receptor variant N190K is unresponsive to peptide agonists yet can be rescued by small-molecule drugsJean-Philippe Fortin, Lei Ci, Jonathan Schroeder, et al.

Pageof 1